Last reviewed · How we verify
NCT06687148: GCASID
Global Changes Associated With Sacroiliac Joint Dysfunction
NA trial testing Manual manipulation in Sacroiliac Dysfunction in 21 participants. Not yet recruiting.
30 May 2025
Quick facts
| Lead sponsor | Aveiro University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 1 April 2025 |
| Primary completion | 30 May 2025 |
| Estimated completion | 12 June 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Manual manipulation
- Sham manipulation
Conditions studied
- Sacroiliac Dysfunction — all drugs for Sacroiliac Dysfunction →
Sponsor
Aveiro University
Who can join
Adults 18 to 30, any sex, with Sacroiliac Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
* Summary Sacroiliac joint dysfunction (ASI) is an alteration in the normal biomechanics of the joint, which leads to hypomobility or hypermobility of that joint. It is one of the most common causes of misdiagnosis in low back pain and when not treated correctly, it often evolves into chronic pain (30% to 42%) and disability. Manipulating the dysfunctional ASI appears to result in benefits and significantly positive changes at various levels, in all segments of the human body. With this investigation, we intend to clarify and deepen the possible correlation between the changes that normally accompany this dysfunction, as well as its possible reversibility with its normalization. * Objectives The investigators will essentially have two main objectives: 1. Mapping of the most evident symptomatic changes, when sacroiliac joint dysfunction is present, in terms of pain and muscle tone; 2. To try to understand the immediate, global and immediate effect of ASI manipulation. * Study design Quantitative, with experimental study design, with the sample comprising individuals with SIJ dysfunction, where all participants will be randomly allocated to the experimental, control and sham groups. It will be carried out at the University of Aveiro facilities. Initially, we will assess the participants with sacroiliac dysfunction. The experimental will be manipulated, the control group will do nothing, and the sham group will be submitted to a hypothetical manipulation (sham manipulation). Consequently, the patients will be assessed again, measuring the subjective and objective degree of pain and muscle tone. \- Material and methods We will make use of: * Standing flexion test; * Sitting Flexion Test; * Faber Test; * EVA , to subjectively assess pain; * Pressure algometer, to objectively assess pain ; * MyotonPro, to assess muscle tone;
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06687148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Aveiro University trials
Trials by the same sponsor.
- NCT06782893 — Chronic COUGH Management in Interstitial Lung DisEase · NA · not yet recruiting
- NCT07366580 — TOUCHminds: Help-seeking in Adolescents With Anxiety · NA · not yet recruiting
- NCT07505537 — Using BlazePod® for Pre-Season Screening of Lower Limb Injury Risk · not yet recruiting
- NCT07424274 — Physiotherapy Interventions on Functional Capacity, Balance and Mental Domains in Community-Dwelling Older Adults: A Ran · NA · not yet recruiting
- NCT06895720 — THE MYOFASCIAL SYSTEM AND MINIMIZING THE RISK OS INJURY IN SPORT · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06687148 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aveiro University
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06687148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing